Search

In order to mitigate the security threat of quantum computers, NIST is undertaking a process to standardize post-quantum cryptosystems, aiming to assess their security and speed up their adoption in production scenarios. Several hardware and software implementations have been proposed for each candidate, while only a few target heterogeneous platforms featuring CPUs and FPGAs. This work presents a HW/SW co-design of BIKE for embedded platforms featuring both CPUs and small FPGAs and employs high-level synthesis (HLS) to timely deliver the hardware accelerators. In contrast to state-of-the-art solutions targeting performance-optimized HLS accelerators, the proposed solution targets the small FPGAs implemented in the heterogeneous platforms for embedded systems. Compared to the software-only execution of BIKE, the experimental results collected on the systems-on-chip of the entire Xilinx Zynq-7000 family highlight a performance speedup ranging from 1.37x, on Z-7010, to 2.78x, on Z-7020.

The synthesis and the physicochemical and biological characterization of a series of carnosine amides bearing on the amido group alkyl substituents endowed with different lipophilicity are described. All synthesized products display carnosine-like properties differentiating from the lead for their high serum stability. They are able to complex Cu(2+) ions at physiological pH with the same stoichiometry as carnosine. The newly synthesized compounds display highly significant copper ion sequestering ability and are capable of protecting LDL from oxidation catalyzed by Cu(2+) ions, the most active compounds being the most hydrophilic ones. All the synthesized amides show quite potent carnosine-like HNE quenching activity; in particular, 7d, the member of the series selected for this kind of study, is able to cross the blood-brain barrier (BBB) and to protect primary mouse hippocampal neurons against HNE-induced death. These products can be considered metabolically stable analogues of carnosine and are worthy of additional investigation as potential neuroprotective agents.

The synthesis, physico-chemical, and biological characterisation of a short series of carnosine amides bearing NO-donor nitrooxy functionalities are described. The NO-donor carnosine analogues and their des-NO derivatives display carnosine-like properties, differing from the lead for their high serum stability. The newly-synthesised compounds are able to complex Cu(2+) ions at physiological pH, displaying significant copper ion sequestering ability, and protect LDL from oxidation catalysed by Cu(2+) ions. All products show moderately-potent HNE quenching activity. The NO-donor compounds 7c-f relaxed rat aorta strips via an NO-dependent mechanism. In vivo evaluation of organ protection in a model of cerebral ischaemia/reperfusion injury, using the selected NO-donor 7e and its des-NO analogue 7a, showed that both derivatives protect from hypoxia-induced brain damage, at lower concentrations than carnosine; 7e also decreased serum TNF-α levels. This class of NO-donor carnosine amides is worthy of further study as potential tools for treating a wide range of chronic vascular and neurodegenerative diseases in which NO-bioavailability is reduced.